Related by context. All words. (Click for frequent words.) 63 Novartis Afinitor 62 Bayer Nexavar 62 DCVax Brain 62 drug Treanda 61 Sutent sunitinib 59 relapsing remitting MS RRMS 59 Tocosol Paclitaxel 59 brachytherapy implants 59 metastatic gastric 59 drug figitumumab 59 Gleevec imatinib 58 Canvaxin 58 DCVax 58 OncoVex 58 refractory acute myeloid 58 Oncophage 58 hepatitis B vaccine Heplisav 58 produces radioisotopes 58 OvaRex ® MAb 58 recurrent metastatic 58 Diamyd ® 58 Onrigin 58 Nexavar sorafenib 57 commercialize deforolimus 57 vaccine Stimuvax 57 Alimta pemetrexed 57 nonsmall cell lung cancer 57 Medullary thyroid cancer 57 Roche Herceptin 57 trastuzumab DM1 57 Merck KGaA Erbitux 57 pediatric acute lymphoblastic 57 Chronic lymphocytic leukemia 57 Cloretazine 57 Rilutek 57 DiabeCell 57 Bonefos 56 Degarelix 56 Tolamba 56 paromomycin 56 Allovectin 7 ® 56 Velcade bortezomib 56 Hepatocellular Carcinoma HCC 56 Kaposi sarcoma KS 56 Zytiga 56 Temsirolimus 56 OHR/AVR# 56 Glivec imatinib 56 ixabepilone 56 Rituxan rituximab 56 Provenge prostate cancer 56 targeted biologic therapies 56 Certolizumab pegol 56 Erbitux cetuximab 56 Artificial pancreas 56 Antisoma Plc 56 drug belatacept 56 pemphigus vulgaris 56 relapsed MM 56 BLP# 56 Amrubicin 56 malignant ascites 56 Nephrology Dialysis Transplantation 56 Alessandro Riva 56 paclitaxel poliglumex 56 Nexavar tablets 56 Tykerb lapatinib 56 Arzerra ofatumumab 56 gastrointestinal stromal tumors GIST 56 OncoVAX ® 56 ImClone Erbitux 56 Lilly Gemzar 56 OvaRex 56 motesanib 56 quinacrine 55 Afatinib 55 vinflunine 55 metastatic bladder 55 Fingolimod 55 Hodgkin lymphoma HL 55 oral Hycamtin 55 BrachySil TM 55 chronic thromboembolic pulmonary 55 Arranon 55 MyVax 55 HNSCC 55 AML acute myeloid 55 chemotherapeutic regimen 55 surgically resectable 55 mertansine 55 Diamyd r 55 PROSTVAC TM 55 biliary tract cancer 55 Vectibix panitumumab 55 Lancet Oncology journal 55 Tarceva erlotinib 55 drug Recentin 55 Bayer HealthCare Onyx Pharmaceuticals 55 Taxotere docetaxel 55 allogeneic HSCT 55 journal Rheumatology 55 Certican 55 Vidaza azacitidine 55 bile duct cancers 55 Gattex 55 hepatorenal syndrome 55 Neuvenge 55 benign uterine 55 metastatic kidney 55 stage IIIB IV 55 underwent liver transplantation 55 OvPlex 55 Gleevac 55 vismodegib 55 Iressa gefitinib 55 DCVax R Brain 55 refractory APL 55 metastatic HER2 positive 55 LBH# 55 Jevtana 55 metastatic malignant 55 Lung transplantation 55 Cellcept 55 advanced medullary thyroid 55 rituximab Rituxan 55 tolevamer 55 Riluzole 55 metastatic ovarian cancer 54 SIR Spheres 54 Remune 54 PSMA ADC 54 midstage trials 54 immunotherapeutic vaccine 54 Safinamide 54 Zybrestat 54 Bevacizumab Avastin 54 cediranib 54 hepatocellular carcinoma liver 54 MAGE A3 ASCI 54 squamous cell lung cancer 54 Allovectin 7 54 eflornithine 54 recurrent malignant glioma 54 deCODE ProstateCancer TM 54 metastatic lung cancer 54 daily subcutaneous injections 54 iniparib 54 resected pancreatic cancer 54 adjuvant colon cancer 54 Sprycel dasatinib 54 phase IIb trial 54 Shark cartilage 54 midstage clinical 54 skeletal metastases 54 corticosteroid dexamethasone 54 AVAiL 54 Cabazitaxel 54 relapsed GBM 54 Phase IIIb study 54 YONDELIS 54 mutated K ras 54 Hycamtin 54 recurrent glioblastoma multiforme 54 Dendreon Provenge 54 gene BRCA2 54 seminoma 54 hPAM4 54 HepaMate 54 adipose derived stem cell 54 Enbrel rheumatoid arthritis 54 Roche Xeloda 54 genitourinary cancers 54 RSR# 54 Avastin bevacizumab 54 advanced metastatic prostate 54 bladder ovarian 54 MabThera rituximab 54 recurrent glioblastoma multiforme GBM 54 liver transplant recipients 54 Kepivance 54 Sebivo 53 colorectal lung 53 neratinib 53 eribulin mesylate 53 Revlimid lenalidomide 53 Pirfenidone 53 chemotherapy cisplatin 53 chronic leukemias 53 pancreatitis inflammation 53 autologous transplants 53 Motesanib 53 IIa trials 53 unresectable tumors 53 axitinib 53 Corlux 53 Crizotinib 53 cetuximab Erbitux 53 OncoVAX 53 Oxaliplatin 53 advanced HER2 positive 53 gallium nitrate 53 BREVAGen ™ 53 Adjuvant chemotherapy 53 urothelial cancer 53 Stage IIB 53 invasive candidiasis 53 Eloxatin oxaliplatin 53 Aplidin 53 Carbaglu 53 olaparib 53 metastatic renal cell 53 Chronic lymphocytic leukemia CLL 53 Gemzar gemcitabine 53 Orathecin 53 Folotyn 53 Hydroxyurea 53 cisplatin chemotherapy 53 indolent lymphoma 53 Cinquil 53 neuroendocrine cancers 53 vaccine Provenge 53 gastrointestinal stromal tumors GISTs 53 Plaquenil 53 leukemia lymphomas 53 Bendamustine 53 NovoTTF 53 SNT MC# 53 relapsed leukemia 53 TEMODAL 53 Lupuzor 53 Zemplar Capsules 53 Votrient 53 Torisel temsirolimus 53 bevacizumab Avastin 53 LHRH receptor positive 53 multicenter Phase II 53 Gleevec imatinib mesylate 53 Alequel 53 LungSign TM 53 dacarbazine chemotherapy 53 humanised monoclonal antibody 53 TheraSphere 53 mitoxantrone plus 53 thetreatment 53 bronchogenic carcinoma 53 urologic diseases 53 cervical precancers 53 Egrifta 53 diagnosed glioblastoma 53 canakinumab 53 drug Lemtrada 53 DCVax ® Brain 53 curative therapy 53 smoldering myeloma 53 Mycograb 53 kidney urologic 53 Reolysin 53 Temodar ® 53 adjuvant cisplatin 53 lymphocytic leukemia 53 cellular immunotherapy 53 paclitaxel Taxol R 53 BCR ABL inhibitor 53 riociguat 53 Eliquis 53 Non Hodgkins lymphoma 53 Pfizer Sutent 53 nonmetastatic 53 RoACTEMRA 53 Surgical resection 53 acute myeloid 53 operable breast cancer 53 intravenous immunoglobulin IVIg 53 TASKi3 53 iniparib BSI 53 Protectan 53 lymphomas leukemias 53 STRIDE PD 53 sorafenib Nexavar 53 KRAS oncogene 53 Roche Avastin 52 demonstrated antitumor activity 52 gastrointestinal stromal tumors 52 PROLARIS 52 haematological cancers 52 metastatic colorectal 52 enlarged prostate glands 52 Inhaled nitric oxide 52 concurrent chemoradiation 52 Xelox 52 Azacitidine 52 recurrent GBM 52 gefitinib Iressa 52 pancreatic ductal 52 HIV HCV coinfected 52 stem cell transplantations 52 colorectal cancer liver metastases 52 Syncria 52 Waldenstrom macroglobulinemia 52 pazopanib 52 antibiotic regimens 52 clazosentan 52 randomized multicenter Phase III 52 radiation therapy SBRT 52 therapies ACTs 52 induced anemia 52 Kantarjian 52 SCIg 52 Novo Nordisk Victoza 52 irinotecan chemotherapy 52 Chronic pancreatitis 52 antiangiogenic therapy 52 MYCN amplification 52 Civacir 52 efficacious treatments 52 vemurafenib 52 DIABECELL ® 52 localized renal 52 PTK# 52 Madin Darby canine 52 figitumumab 52 Avastin adjuvant 52 chromium supplementation 52 Annamycin 52 vorinostat 52 OVARIAN 52 pancreatic neuroendocrine tumors 52 Herceptin trastuzumab 52 symptomatic paroxysmal AF 52 ALK inhibitors 52 malignant pleural mesothelioma 52 Gynecologic Oncology Group 52 Advexin 52 paricalcitol 52 unresectable liver cancer 52 pain palliation 52 refractory myeloma 52 Axitinib 52 metastatic castrate resistant 52 chronic HBV 52 TBC# 52 CBLC# 52 darbepoetin alfa Aranesp 52 Xyotax 52 MYDICAR 52 midstage clinical trial 52 adult chronic ITP 52 sickest colon cancer 52 peritoneal cancer 52 cytoreduction 52 Torisel 52 clinically detectable 52 NeuroVax 52 treat premature ejaculation 52 KRAS status 52 Xgeva 52 Xience V stent 52 noscapine 52 Pulminiq 52 multiple myeloma MM 52 kidney fibrosis 52 indolent NHL 52 Panzem 52 prostate cancer PCa 52 Rectal cancer 52 Mylotarg 52 antibiotic streptomycin 52 testicular germ cell 52 gastrointestinal stromal tumor GIST 52 Zavesca 52 Sanofi Aventis Taxotere 52 SJIA 52 ChronVac C R 52 phase IIa 52 ReN# therapy 52 monoinfected patients 52 radiolabeled TM# 52 Zolinza 52 aerosolized KL4 surfactant 52 trastuzumab Herceptin ® 52 acute lymphoblastic 52 tumor histology 52 Amgen Vectibix 52 MMP inhibitor 52 immunological diseases 52 patientswith 52 Frovatriptan 52 recurrent bladder 52 radioimmunotherapy RIT 52 subcutaneous methylnaltrexone 52 antitumor effect 52 ReN# 52 myoblast therapy 52 ER CHOP 52 Campath alemtuzumab 52 hormonally responsive 52 refractory Hodgkin 52 miglustat 52 dirucotide MBP# 52 erlotinib Tarceva 52 InSync Sentry 52 ticagrelor Brilinta 52 childhood acute lymphoblastic 52 oral methylnaltrexone 52 transgenic rats 52 mismatched bone marrow 52 Radical prostatectomy 52 PRIMO CABG 52 Zactima 52 psoriasis Crohn disease 52 TransMID TM 52 standard chemotherapy regimen 52 biotherapies 52 Tumors shrank 52 Quinamed 52 lymphatic cancers 52 pegylated liposomal doxorubicin 52 pancreatic transplantation 52 late onset Pompe 52 microsphere therapy 52 IV melanoma 52 blood clot preventer prasugrel 52 stage IIIb IV 52 multicentre study 52 Abiraterone acetate 52 immunosuppressive medication 52 Gliadel Wafer 52 Zemplar 52 cetrorelix pamoate 52 Tyverb 52 Cancidas 52 liver metastasis 52 lumiliximab 52 Mipomersen 52 edifoligide 52 Uplyso 52 lupus nephritis 51 Theratope 51 vascular thrombosis 51 rindopepimut 51 ASCEND HF 51 Zarnestra 51 #mg ATC 51 malignant lymphoma 51 chronic myeloid 51 neuro degenerative disorders 51 neuroblastoma tumors 51 Asentar 51 Alemtuzumab 51 OncoGel 51 differentiated thyroid 51 Homocysteine levels 51 bioabsorbable stent 51 GnRH analogue 51 cervical cancer vaccine Cervarix 51 FOLFIRINOX 51 radioiodine therapy 51 underwent resection 51 follicular Non Hodgkin 51 biotherapy 51 Hectorol 51 preoperative chemotherapy 51 chemoradiation therapy 51 intermittent dosing 51 phase Ib 51 PhG alpha 1 51 antibiotic telavancin 51 vandetanib 51 cancerdefine 51 HERCEPTIN 51 blood clot preventer 51 Vimpat ® lacosamide 51 taxane chemotherapy 51 brentuximab 51 Ataluren 51 GVAX 51 acute HAE attacks 51 GRN# 51 Novartis Zometa 51 CellCept mycophenolate mofetil 51 Tibolone 51 oral clodronate 51 leukemia AML 51 ToGA 51 intra arterial chemotherapy 51 relapsed ALL 51 VitiGam 51 autologous hematopoietic stem cell 51 Lantus insulin glargine 51 Evoltra TM 51 Affinitak 51 Novartis AG Gleevec 51 renal transplants 51 induce remission 51 stereotactic radiotherapy 51 cytotoxic therapies 51 metastatic renal cell carcinoma 51 Arimidex anastrozole 51 TNF alpha inhibitor 51 Prolastin C 51 efalizumab 51 thalidomide Thalomid 51 cilengitide 51 intravenous cyclophosphamide 51 AstraZeneca Iressa 51 anti angiogenic agents 51 Polyphenon E 51 K ras gene 51 GIST tumors 51 inecalcitol 51 Fablyn 51 penicillin allergy 51 ACOSOG Z# 51 Vernakalant 51 statin Crestor 51 HepaSphere Microspheres 51 GeneICE 51 PrevOnco ™ 51 Urocidin 51 Helicobacter pylori eradication 51 Caelyx 51 amrubicin 51 refractory chronic myeloid 51 abacavir Ziagen 51 Zavesca R 51 relapsed ovarian cancer 51 sodium stibogluconate 51 IVIG therapy 51 Tarceva TM 51 basal cell skin 51 zoledronic acid Zometa 51 Teverelix 51 Ontak 51 immune thrombocytopenic purpura ITP 51 intraductal 51 AIR2 Trial 51 precancerous spots 51 tafamidis 51 hereditary deficiency 51 superficial bladder cancer 51 Pazopanib 51 ovarian prostate 51 Insulin detemir 51 Femara letrozole 51 StemEx R 51 Isentress raltegravir 51 gemcitabine chemotherapy 51 NewsRx.com Data 51 silibinin 51 Advagraf 51 interferon ribavirin 51 Selective Internal 51 taxotere 51 nucleotide analogue 51 operable pancreatic cancer 51 metastatic testicular cancer 51 cervical lymph node 51 undergoing radical cystectomy 51 peritoneal carcinomatosis 51 Colostrinin 51 MVA MUC1 IL2 51 novel therapeutic antibodies 51 haematologic 51 Vandetanib 51 lung liver pancreas 51 BCIRG 51 abiraterone 51 BETAS 51 advanced epithelial ovarian 51 experimental hepatitis C 51 rALLy trial 51 embryo clones 51 palliative radiotherapy 51 Kidney transplantation 51 treating cancerous tumors 51 Cyclosporin 51 pancreatic islet cell 51 Ceflatonin 51 estramustine 51 transplanted islets 51 TTF Therapy 51 nonmelanoma 51 commercializes oncology 51 acute mania 51 malignant pheochromocytoma 51 Cladribine 51 anti CD3 antibody 51 Taxotere chemotherapy 51 diagnostic biomarker 51 metastatic renal 51 MGd 51 refractory metastatic 51 mTOR inhibition 51 Acapodene 51 infliximab Remicade 51 anti angiogenic therapy 51 immunomodulatory therapy 51 immunosuppression therapy 51 chemical entities NCEs 51 EchoCRT 51 nucleoside analogs 51 gatifloxacin 51 Privigen 51 intra abdominal abscess 51 Lymph node 51 methylnaltrexone 50 de novo kidney transplant 50 prostate carcinomas 50 gynaecologic 50 alkylating agent 50 cytotoxic therapy 50 rimonabant Acomplia 50 malignant neoplasm 50 Omnitarg 50 intravitreal insert 50 anaplastic astrocytoma 50 HepDirect prodrug 50 raloxifene Evista 50 cisplatin resistant 50 TRUS biopsy 50 KRAS mutated 50 ductal carcinomas 50 cranial radiation 50 trials RCTs 50 follicular lymphoma FL 50 chronic hepatitis cirrhosis 50 ACTEMRA TM 50 trabectedin 50 Onko Sure IVD 50 APTIVUS R 50 Circulating tumor cells 50 thymic carcinoma 50 temozolomide Temodar 50 sitaxsentan 50 clot busting therapy 50 CELVAPAN H#N# 50 EndoTAGTM 1 50 haematopoietic stem cell 50 EGFRIs 50 Rutherford Procedure 50 QuadraSphere 50 inhaled cyclosporine 50 treat enlarged prostate 50 pancreatic adenocarcinoma 50 Malignant tumors 50 liver transplantations 50 spontaneous regression 50 diagnose Alzheimer disease 50 hormone refractory metastatic prostate 50 renal carcinoma 50 cancerous polyp 50 Alteplase 50 rufinamide 50 Humira adalimumab 50 AGHD 50 immunosuppressive therapies 50 multicenter trials 50 Proxinium TM 50 Proleukin 50 Trovax 50 hematological diseases 50 UCB Cimzia 50 Hormone pills 50 maximally tolerated lipid lowering 50 Pegintron 50 androgen ablation 50 lenalidomide dexamethasone 50 Yondelis 50 Desmoteplase 50 etanercept Enbrel 50 Dasatinib 50 blood thinner Xarelto 50 Kynapid 50 BR.# 50 parthenolide 50 precancerous tumors 50 mapatumumab 50 conformal radiotherapy 50 exemestane Aromasin 50 ZACTIMA 50 infused intravenously 50 refractory angina 50 drug Zoladex 50 Etravirine 50 iron chelators 50 Eliezer Zomer Ph.D. 50 Aflibercept 50 Oncotype DX colon cancer 50 Basal Cell 50 Stereotactic body 50 methotrexate therapy 50 Behcet uveitis 50 dexanabinol 50 thymoma 50 nephrosis 50 non hodgkin lymphoma 50 postoperative chemotherapy 50 beam radiotherapy 50 autologous transplant 50 Erbitux ImClone 50 sipuleucel T Provenge 50 isradipine 50 Simponi golimumab 50 gepirone ER 50 basal cell carcinoma BCC 50 Basal cell 50 Lucrin 50 Anaplastic 50 hormonally sensitive 50 prospective observational cohort 50 rheumatic arthritis 50 sirtuin activators 50 BRAF V# mutation 50 pilocytic astrocytoma 50 radiologic imaging 50 Fusilev 50 Avandia Actos 50 T1a 50 TroVax ® 50 DEB# 50 prostate adenocarcinoma 50 EFAPROXYN 50 Factor Xa inhibitor 50 Phase 2b kidney transplant 50 intravenous bisphosphonates 50 Prostate AdenoCarcinoma Treatment 50 Alzhemed 50 Heplisav 50 recurrent ovarian 50 Accelerated Partial Breast Irradiation 50 Neumune 50 acyclovir Lauriad R 50 recurrent glioblastoma 50 Yervoy 50 liposomal doxorubicin 50 faulty BRCA genes 50 daclizumab 50 EECP ® therapy 50 locoregional recurrence 50 murine models 50 vivo validation 50 pulmonary metastasis 50 OSI Tarceva 50 Sipuleucel T 50 Cell Lymphoma CTCL 50 Tectin TM 50 allogeneic bone marrow 50 p# biomarker 50 midstage clinical trials 50 weekly intravenous infusions 50 afamelanotide 50 decompensated cirrhosis 50 diagnose coronary artery 50 Mepact 50 pouchitis 50 ORENCIA R 50 aromatase inhibitor therapy 50 benign prostatic hypertrophy BPH 50 cells multiply uncontrollably 50 reslizumab 50 leukemias lymphomas 50 Bezielle 50 TransVax 50 Lucentis injections 50 chemoprevention trials 50 Temodar temozolomide 50 Aviptadil 50 pediatric malignancies 50 eribulin 50 GALNS 50 prostate cancer metastases 50 X Excite 50 AVASTIN 50 neurologic progression 50 Mabthera 50 ASA# 50 OncoVEX 50 TransMID 50 AKT inhibitor 50 gemcitabine carboplatin 50 pregabalin Lyrica 50 CLL8 50 DCVax R 50 AE# vaccine 50 IV malignant melanoma 50 ACZ# 50 pamidronate 50 nasopharyngeal carcinoma 50 Hormone Refractory Prostate Cancer 50 clevidipine 50 myelodysplastic syndromes 50 bortezomib Velcade 50 gastric adenocarcinoma 50 Onconase 50 sero positive 50 cysteamine bitartrate 50 postoperative radiotherapy 50 pelvic malignancies 50 PF # [002] 50 calcineurin inhibitor 50 ProSavin 50 uterine fibroid 50 clinical trials 50 multiorgan 50 Fodosine 50 dalbavancin 50 Camptosar ® 50 Lodamin 50 ISEL 50 type 1diabetes 50 Uterine cancer 50 SCENESSE ® 50 Gefitinib 50 Abiraterone 50 NSABP C 50 Hematopoietic stem cell 50 Major Depressive Disorder MDD 50 stem cell engraftment 50 chlamydial infections 50 tremelimumab 49 cinacalcet 49 antithrombotic agents 49 metastatic castration resistant 49 Roche Holding AG ROG.VX 49 medulloblastoma tumors 49 differentiating squamous 49 NV1FGF 49 CardioFit 49 ZOLINZA 49 phase IIb clinical 49 eBx 49 generation purine nucleoside 49 fluvastatin 49 Genetic mutation 49 journal PloS ONE 49 metastatic hormone refractory 49 Faslodex 49 oral antiplatelet agent 49 metastatic malignant melanoma 49 chronic Hepatitis B 49 AVONEX PEN 49 Anthracycline 49 lumbar spinal stenosis LSS 49 Ceplene/IL-2 49 microwave hyperthermia 49 samalizumab 49 SEER database 49 BoNTA 49 primary hyperparathyroidism 49 refractory colorectal cancer 49 metastatic adenocarcinoma 49 ductal breast cancer 49 clinically localized prostate 49 tuberous sclerosis TS 49 antibody MAb 49 Legg Calvé Perthes disease 49 intravenous diuretics 49 anagrelide 49 LC#m# 49 vaccine Prevenar 49 liver scarring 49 antihypertensive therapy 49 epoetin alpha 49 dexpramipexole 49 MIBG 49 Solorel 49 MALT lymphoma 49 acute lymphoid leukemia 49 Sandostatin LAR Depot 49 ROCHESTER Minn. Mayo Clinic 49 Corus CAD 49 rheumatoid arthritis sufferers 49 PCA3 assay 49 insulin glulisine 49 immune suppressing 49 Combivir Kivexa 49 blood clot dissolver 49 REMINYL ® 49 midstage studies 49 VIR# 49 neoadjuvant therapy 49 novel immunotherapies 49 sacral nerve stimulation 49 aprepitant 49 cytogenic 49 Telcyta 49 previously untreated follicular 49 cisplatin gemcitabine 49 leukaemias 49 docetaxel Taxotere 49 rBChE 49 torcetrapib atorvastatin 49 journal Diabetologia 49 DCVax ® 49 BRIM2 49 fumagillin nanoparticles 49 plasminogen activators 49 antiangiogenic drugs 49 allogeneic hematopoietic stem cell 49 Arcalyst 49 RRMS patients 49 Factor Xa inhibitors 49 corifollitropin alfa 49 nonmelanoma skin cancers 49 romiplostim 49 secretin 49 Glioblastoma Multiforme 49 Novartis Glivec 49 GRNCM1 49 nodal metastasis 49 PET CT scanning 49 levocetirizine 49 refractory ovarian cancer 49 verteporfin 49 baminercept 49 invasive ductal breast cancer 49 Treanda 49 Pemetrexed 49 HAART regimen 49 bioartificial kidney 49 osteoarthritic pain 49 NATRECOR ® 49 chemo radiotherapy 49 Natalizumab 49 recurrent prostate cancer 49 Halaven 49 HBV vaccination 49 androgen receptor antagonist 49 chemoradiotherapy 49 ASPIRE HIGHER 49 RhuDex 49 Apatone 49 stem cells CSCs 49 temsirolimus 49 Instanyl 49 DIABECELL 49 REOLYSIN ® 49 IIa clinical trials 49 neoadjuvant setting 49 induced hepatotoxicity 49 Neural stem cells 49 ARIXTRA R 49 MastaScope 49 Pancreate ™ 49 PYY nasal spray 49 docetaxel Taxotere ® 49 imexon 49 adjuvant tamoxifen 49 ancrod 49 MS spasticity 49 Trofex 49 AGILECT R 49 oral pharyngeal 49 HuMax Inflam 49 albumin bound paclitaxel 49 Deforolimus 49 Platinol ® cisplatin 49 intravenous immunoglobulin 49 Genentech Herceptin 49 TNM classification 49 grade serous ovarian 49 TNF alpha antagonist 49 Acute myelogenous leukemia 49 TRIST study 49 brain metastases originating 49 Squamous Cell 49 receptor inhibitor 49 Crohn colitis 49 androgen suppression therapy 49 dose escalation clinical 49 docetaxel chemotherapy 49 GVAX ® 49 Sentinel node biopsy 49 virotherapy 49 Myelodysplastic Syndrome MDS 49 CYT# QbG# 49 oxypurinol 49 Gleevec resistant 49 CRF antagonists 49 Intravitreal 49 Meningiomas 49 EGFR mutation positive 49 agomelatine 49 Zymafos 49 T1c 49 immunosuppressive regimens 49 Retacrit 49 CytoFab 49 lymphoid malignancies 49 Molecular Cancer 49 Pertuzumab 49 colorectal metastases 49 Celgene Revlimid 49 2DG 49 treatments 49 hypophosphatasia 49 familial hypercholesterolaemia FH 49 ductal adenocarcinoma 49 double blinded randomized